These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1907554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin.
    Taylor JE, MacTier RA, Henderson IS, Belch JJ, Stewart WK.
    Perit Dial Int; 1992 May; 12(2):221-6. PubMed ID: 1586685
    [Abstract] [Full Text] [Related]

  • 8. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992 May; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 9. [Anemia in peritoneal dialysis patients].
    Lausević M, Nesić V, Jovanović N, Stojimirović B.
    Srp Arh Celok Lek; 2006 May; 134(3-4):133-7. PubMed ID: 16915754
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 May; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V, Martimbianco L, Vasile A.
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C, Balzar E, Steger H, Lothaller MA, Frenzel K, Kohlhauser C, Kiss H, Khoss AE, Kernova T.
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [Abstract] [Full Text] [Related]

  • 20. Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?
    Eschbach JW, Varma A, Stivelman JC.
    Nephrol Dial Transplant; 2002 Nov; 17 Suppl 5():2-7. PubMed ID: 12091599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.